Concordant Validity of a Digital Peak Cough Flow Meter to Assess Voluntary Cough Strength in Individuals with ALS
- 29 Downloads
Peak cough flow represents an important metric directly related to the physiologic ability of an individual to defend the airway or expel tracheal aspirate. Given the high prevalence of dysphagia and dystussia in individuals with amyotrophic lateral sclerosis (ALS) and recent findings that the expiratory phase of voluntary cough is significantly impaired in ALS individuals, we aimed to determine the reproducibility of an affordable, portable peak cough flow (PCF) meter for the assessment of cough production in individuals with ALS. 109 individuals with ALS completed voluntary cough testing using both the research cough spirometry equipment and a digital peak cough flow meter. Maximum peak expiratory cough flow rates were obtained from each device. Analyses included paired t test, Pearson’s correlation, and Lin’s concordance correlation to determine the degree of agreement and reproducibility between cough measurement devices (alpha = 0.05). Mean differences between peak cough flow test values (L/min) across instruments were not statistically significant (mean difference = − 2.93; 95% CI − 18.67, 12.82; p = 0.713). PCF values obtained from the digital peak cough flow meter and the research cough spirometry equipment were strongly associated (r = 0.826, p < 0.000) and demonstrated a high level of agreement and reproducibility (ρc = 0.824, 95% CI 0.754, 0.876). These data validate the use of an inexpensive and portable digital peak cough flow device to index peak cough flow strength in individuals with ALS. This assessment could easily be incorporated into a multidisciplinary ALS clinical setting to index the physiologic ability of an individual to protect the airway.
KeywordsCough Deglutition Deglutition disorders Airway protection Amyotrophic lateral sclerosis
This study was funded by the National Institute of Neurological Disorders and Stroke (1R01 NS100859), the Amyotrophic Lateral Sclerosis Association Clinical Management Grant, the University of Florida Breathing Research and Therapeutics Training Program (T32HL134621), and the Center for Respiratory Research and Rehabilitation.
Compliance with Ethical Standards
Conflict of interest
The authors declare they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 2.Mehta P, Antao V, Kaye W, Sanchez M, Williamson D, Bryan L, Muravov O, Horton K. Prevalence of amyotrophic lateral sclerosis—United States, 2010–2011. MMWR Surveill Summ. 2014;63(7):1–13.Google Scholar
- 6.Ruoppolo G, Schettino I, Frasca V, Giacomelli E, Prosperini L, Cambieri C, Roma R, Greco A, Mancini P, De Vincentiis M, Silani V, Inghilleri M. Dysphagia in amyotrophic lateral sclerosis: prevalence and clinical findings. Acta Neurol Scand. 2013;128(6):397–401. https://doi.org/10.1111/ane.12136.CrossRefGoogle Scholar
- 7.Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1218–26. https://doi.org/10.1212/WNL.0b013e3181bc0141.CrossRefGoogle Scholar
- 8.Marin B, Beghi E, Vial C, Bernard E, Lautrette G, Clavelou P, Guy N, Lemasson G, Debruxelles S, Cintas P, Antoine JC, Camdessanche JP, Logroscino G, Preux PM, Couratier P. Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres. Eur J Neurol. 2016;23(4):787–95. https://doi.org/10.1111/ene.12941.CrossRefGoogle Scholar
- 10.Pattee GL, Plowman EK, Brooks BR, Berry JD, Atassi N, Chapin JL, Garand K, Yunusova Y, McIlduff CE, Young E, Costello JM, Macklin EA, Locatelli ER, Silani V, Heitzman D, Wymer J, Goutman SA, Gelinas DF, Smith R, Perry B, Nalipinski P, Stipancic K, O'Brien M, Sullivan SL, Green J. Best practices protocol for the evaluation of bulbar dysfunction: summary recommendations from the NEALS bulbar subcommittee symposium. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(3–4):311–2. https://doi.org/10.1080/21678421.2017.1404109.CrossRefGoogle Scholar
- 11.Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1227–333. https://doi.org/10.1212/WNL.0b013e3181bc01a4.CrossRefGoogle Scholar
- 12.Association ASLaH, Clinical indicators for instrumental assessment of dysphagia (guidelines). ASHA Suppl. 2000;20:18–9.Google Scholar
- 17.Miles A, Zeng ISL, McLauchlan H, Huckabee ML. Cough reflex testing in dysphagia following stroke: a randomized controlled trial. J Clin Med Res. 2013;5(3):222–33.Google Scholar
- 18.Boitano LJ (2006) Management of airway clearance in neuromuscular disease. Respir Care 51(8):913–922; discussion 922–914 Google Scholar
- 28.Plowman E, Tabor Gray L, Magennis K, Chapin J, Robison R, Anderson A, Vasilopoulos T, Wymer J. Validation of the physiologic risk index for swallowing impairment (PRISIM) in ALS. Paper presented at the Dysphagia Research Society, San Diego, CA; 2019.Google Scholar
- 30.Tilanus TBM, Groothuis JT, TenBroek-Pastoor JMC, Feuth TB, Heijdra YF, Slenders JPL, Doorduin J, Van Engelen BG, Kampelmacher MJ, Raaphorst J. The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosis. Respir Res. 2017;18(1):144. https://doi.org/10.1186/s12931-017-0624-8.CrossRefGoogle Scholar
- 31.Green JR, Yunusova Y, Kuruvilla MS, Wang J, Pattee GL, Synhorst L, Zinman L, Berry JD. Bulbar and speech motor assessment in ALS: challenges and future directions. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(7–8):494–500. https://doi.org/10.3109/21678421.2013.817585.CrossRefGoogle Scholar
- 32.McHorney CA, Rosenbek JC. Functional outcome assessment of adults with oropharyngeal dysphagia. Semin Speech Lang. 1998;19(3):235–246; quiz 247. https://doi.org/10.1055/s-2008-1064047
- 34.Plowman EK, Tabor LC, Wymer J, Pattee G. The evaluation of bulbar dysfunction in amyotrophic lateral sclerosis: survey of clinical practice patterns in the United States. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:351–7. https://doi.org/10.1080/21678421.2017.1313868.CrossRefGoogle Scholar